anesthesia and glp-1 guidance news Guidelines for peri-operative care of GLP-1 RA GIP patients 2025 ADS/ANZCA/GESA/NACOS clinical practice recommendations – glp 1 gastric emptying anesthesia

What's the best storage method for long-term BPC-157 inventory

Tirzepatide Tirzepatide acts on multiple metabolic pathways and may offer enhanced weight loss benefits for select patients

It can also support joint health and reduce inflammation, making it an excellent option for active men looking to optimize their performance and recovery

February 24, 2026: Novo Nordisk Announces Plans to Cut Ozempic List Price by 35%, Personal Injury Lawsuits Continue Novo Nordisk has said it intends to reduce Ozempics list price, starting January 1, 2027

The measures included: Appendicular and trunk fat-free mass (proxy for lean muscle) Whole-body and trunk fat mass Body-fat percentage Waist-to-hip ratio Key Findings The researchers found that for every 1-unit reduction in BMI linked to GLP-1 mimicry: Fat mass decreased by ~7.9 kg Lean mass (muscle) decreased by ~6.4 kg Body-fat percentage dropped by ~4.5% In other words, fat loss exceeded muscle loss in both absolute and relative terms, which supports the use of GLP-1 drugs as a viable treatment for obesity

Electrophysiological evidence for the presence of cystic fibrosis transmembrane conductance regulator (CFTR) in mouse sperm